NIHR Biomedical Research Centre: Oxford

Enabling translational research through partnership

NIHR 20th Anniversary NIHR website
NIHR Biomedical Research Centre: Oxford
  • Home
  • About
    • About us
    • Impact
    • Our next BRC
    • Steering Committee
    • Promoting equality, diversity and inclusion in research
    • Current Vacancies
    • Stay in Touch
    • Contact Us
  • Research
    • Research Overview
      • NIHR Clinical Research Facility
      • Ethics in the NIHR BRC: Oxford
      • Health Economics
      • Medical Statistics
    • Cancer
    • Cardiovascular Medicine
    • Digital Health from Hospital to Home
    • Gene and Cell Therapy
    • Genomic Medicine
    • Imaging
    • Inflammation across Tissues
    • Life-saving Vaccines
    • Metabolic Experimental Medicine
    • Modernising Medical Microbiology and Big Infection Diagnostics
      • Theme overview
      • Infections in Oxfordshire Database (IORD)
    • Musculoskeletal
    • Preventive Neurology
    • Respiratory Medicine
    • Surgical Innovation, Technology and Evaluation
    • Translational Data Science
  • Patient & Public Involvement
    • For patients and the public
    • For researchers
    • More information
  • Training
  • Industry & Partnerships
  • News
  • Events
  • Videos

News

New IVF treatment pioneered in Oxford

4 February 2011 · Listed under Other News

The first babies have now been born in the UK using a new technique pioneered at Oxford University to select the best embryos for IVF.

The advance could bring hope to many British couples struggling to have a child and going through many cycles of IVF treatment.

George and Helen Ashton from Gloucestershire are thought to be the first couple to have babies in the UK after using a technique called microarray CGH with IVF embryos five days after fertilisation.

The technique allows the embryos to be checked for the right number of chromosomes before implantation in an IVF treatment, lessening the chance of miscarriage or Down’s syndrome.

The Ashtons had twins last November following treatment at the Oxford Fertility Unit, an independent IVF clinic which maintains strong research partnerships with the University. The boys, Alex and Louis, are now 11 weeks old.

The strategy of applying microarray CGH, or comparative genomic hybridisation, to five-day-old embryos, or ‘blastocysts’, was developed by Dr Dagan Wells and Dr Elpida Fragouli at the University of Oxford, with funding from the Oxford Biomedical Research Centre and in collaboration with partners in the health services and industry.

← Careers in medicine and science on show
Public Open Day – ‘Your Health, Your Future’ →

Other news

News Categories

News by Month

See all news
You are here: Home > Other News > New IVF treatment pioneered in Oxford

Subscribe to the BRC Oxford Newsletter

Keep informed about the work of the BRC Oxford by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

BRC Oxford on Social Media

  • Bluesky
  • Facebook
  • LinkedIn
  • YouTube
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2026 NIHR Biomedical Research Centre: Oxford